HQY vs PCTY

For growth investors, Paylocity Holding Corporation (PCTY) is the stronger pick with 13.

7% revenue growth year-over-year, versus 9. 5% for HealthEquity, Inc. (HQY). Paylocity Holding Corporation (PCTY) offers the better valuation at 27. 1x trailing P/E (14. 0x forward), making it the more compelling value choice. Analysts rate HealthEquity, Inc. (HQY) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Paylocity Holding Corporation (PCTY) is the cheapest at 27.

1x versus HealthEquity, Inc. at 34. 1x. On forward P/E, Paylocity Holding Corporation is actually cheaper at 14. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: HealthEquity, Inc. wins at 0. 26x versus Paylocity Holding Corporation's 0. 50x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, HealthEquity, Inc.

(HQY) delivered a total return of +12. 7%, compared to -35. 2% for Paylocity Holding Corporation (PCTY). Over 10 years, the gap is even starker: HQY returned +228. 2% versus PCTY's +218. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Paylocity Holding Corporation (PCTY) is the lower-risk stock at 0.

43β versus HealthEquity, Inc. 's 1. 04β — meaning HQY is approximately 142% more volatile than PCTY relative to the S&P 500. On balance sheet safety, HealthEquity, Inc. (HQY) carries a lower debt/equity ratio of 2% versus 18% for Paylocity Holding Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Paylocity Holding Corporation (PCTY) is pulling ahead at 13.

7% versus 9. 5% for HealthEquity, Inc. (HQY). On earnings-per-share growth, the picture is similar: HealthEquity, Inc. grew EPS 125. 7% year-over-year, compared to 10. 7% for Paylocity Holding Corporation. Over a 3-year CAGR, PCTY leads at 23. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

HealthEquity, Inc.

(HQY) is the more profitable company, earning 16. 4% net margin versus 14. 2% for Paylocity Holding Corporation — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HQY leads at 24. 6% versus 19. 1% for PCTY. At the gross margin level — before operating expenses — HQY leads at 69. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, HealthEquity, Inc. (HQY) is the more undervalued stock at a PEG of 0. 26x versus Paylocity Holding Corporation's 0. 50x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Paylocity Holding Corporation (PCTY) trades at 14. 0x forward P/E versus 21. 2x for HealthEquity, Inc. — 7. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PCTY: 54. 0% to $168. 08.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Paylocity Holding Corporation (PCTY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

43), +218. 2% 10Y return). Both have compounded well over 10 years (PCTY: +218. 2%, HQY: +228. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HQY (Healthcare) and PCTY (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.